Technology | September 08, 2014

iCAD Expands Partnership With Volpara Solutions to Offer Enhanced Breast Imaging Analytics for 2-D Mammography and Tomosynthesis

New additions to PowerLook AMP provide radiologists a consistent, standardized way to evaluate performance of breast imaging systems in real time

September 8, 2014 — iCAD Inc. announced that, in addition to Volpara Density volumetric breast density assessment software, Volpara Analytics and Volpara Dose solutions are now available as part of iCAD’s PowerLook Advanced Mammography Platform (AMP). With the addition of these quantitative breast-imaging tools, radiologists will be able to evaluate the performance of all major digital mammography and tomosynthesis units and obtain patient-specific dose information to make informed treatment decisions in real time.

“Today’s healthcare environment is increasingly data-driven and our customers require up-to-the-minute access to analytics that impact patient care,” said Ken Ferry, CEO of iCAD. “By incorporating additional breast imaging analytic and reporting solutions from Volpara, our PowerLook AMP customers will be able to go beyond automated mammography unit settings and mine patient-specific, real-time information for actionable insights regarding care delivery within their practices and across patient populations.”

PowerLook AMP is a next-generation digital mammography computer-aided detection (CAD) platform that provides radiologists with the ability to customize their 2-D CAD solution to meet the needs of their individual work environment. Now with the option to incorporate VolparaAnalytics and VolparaDose in addition to VolparaDensity, PowerLook AMP users will, among other benefits, be able to:

  • Improve patient safety and reporting through personalized measurements of density, patient dose, breast compression and other volumetric factors designed to help maintain accuracy and consistent quality in breast screening.
  • Optimize performance/utilization of staff and mammography systems.
  • Utilize a globally-accepted algorithm incorporating breast density to generate patient-specific radiation dose estimates, which can be automatically entered in patient communications.

Cleared by the U.S. Food and Drug Administration (FDA), HealthCanada, the TGA and CE-marked, VolparaDensity is used by radiologists to objectively assess density from both digital mammography and tomosynthesis images to help doctors evaluate who might benefit from additional screening. Highly correlated to breast magnetic resonance imaging (MR) assessments, VolparaDensity is a reliable tool that automatically generates an objective measurement of volumetric breast density correlated to the ACR (American College of Radiology) breast density categories. To date, more than 3 million women have had their breast density analyzed using VolparaDensity.

For more information:

Related Content

Breast Cancer Follow-up Imaging Varies Widely
News | Breast Imaging | July 13, 2018
July 13, 2018 — Follow-up imaging for women...
Invision Diagnostics Installs VolparaEnterprise Software to Enhance Mammography Image Quality
News | Mammography | July 11, 2018
Invision Diagnostics, a provider of mobile mammography services across North and South Carolina, announced that it is...
The images (before and after) depict a 50 percent dose reduction in chest X-ray without compromising  image quality.

The images (before) depict a 50 percent dose reduction in chest X-ray without compromising
image quality.

Sponsored Content | Case Study | Radiation Dose Management | July 03, 2018
There are a handful of priorities for radiologists: lowest radiation dosage, highest image quality, optimal workflow,...
FDA Article Underscores Benefits of Adequate Breast Compression for Mammography Image Quality
News | Mammography | June 26, 2018
Inadequate breast commission played a role in up to 38 percent of mammogram image quality deficiencies, according to a...
Clinical Trial Testing Topical Gel to Reduce Breast Density
News | Breast Density | June 19, 2018
Women with dense breast tissue soon might be adding a new product to their skincare routine to help them fight breast...
California Women In Favor of Extending State's Breast Density Inform Law
News | Breast Density | June 15, 2018
A recent survey of California women found that 95 percent of respondents want the state’s breast density inform law to...
Women More Likely to Use Other Preventive Health Services Following Mammography
News | Mammography | June 13, 2018
Medicare beneficiaries who undergo breast cancer screening with mammography are more likely than unscreened women to...
Breast imaging technologies have seen a rapid evolution.

Breast imaging technologies have seen a rapid evolution.

Feature | Women's Health | June 05, 2018 | By Jeff Zagoudis
Breast imaging technologies have evolved rapidly in the last two decades to help physicians detect breast cancers at
Latest additions to Somatom go. CT platform address advanced clinical fields and applications, including cardiology, CT-guided intervention and dual energy CT. How to lower radiation dose from Computed tomography scanners using ned technology.

Latest additions to Somatom go. CT platform address advanced clinical fields and applications, including cardiology, CT-guided intervention and dual energy CT.

Feature | Computed Tomography (CT) | June 04, 2018 | By Melinda Taschetta-Millane
Recent studies show a rapid increase in patient radiation exposure mainly due to increased use of medical imaging, pa
Breast Cancer Survivors Not Getting Recommended Number of Mammograms Post-Surgery
News | Mammography | May 24, 2018
Breast cancer survivors are not getting the recommended level of screening post-surgery, according to a newly-published...
Overlay Init